Skip to main content
. 2019 Sep 27;11(9):678–688. doi: 10.4254/wjh.v11.i9.678

Table 1.

Concordance in the treatment of hepatocellular carcinoma proposed by the Hong Kong liver cancer system and Barcelona clinic liver cancer classification

BCLC-0 BCLC-A BCLC-B BCLC-C BCLC-D
(ablation, LR or LT) (ablation, LR or LT) (TACE) (SOR) (ST)
HKLC-I (ablation, LR or LT)
HKLC-IIA (ablation, LR or LT)
HKLC-IIB (LR)
HKLC-IIIA (TACE)
HKLC-IIIB (TACE)
HKLC-IVA (SOR)
HKLC-IVB (SOR or ST)
HKLC-VA (LT)
HKLC-VB (ST)

The tick in the table means that there was agreement in the treatment of HCC proposed by the HKLC system and BCLC classification. BCLC: Barcelona clinic liver cancer; HCC: Hepatocellular carcinoma; HKLC: Hong Kong liver cancer; LR: Liver resection; LT: Liver transplantation; ST: Symptomatic treatment; SOR: Sorafenib; TACE: Transarterial chemoembolization.